News | Interventional Radiology | July 03, 2019

Varian Purchasing Embolic Bead Assets from Boston Scientific

Varian will add the Boston Scientific Portfolio of drug-loadable microsphere and bland embolic bead products for multidisciplinary integrated cancer care

Varian Purchasing Embolic Bead Assets from Boston Scientific

July 3, 2019 — Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Varian's planned acquisition of the Boston Scientific portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products will enable Varian to extend its new interventional oncology platform. The company will benefit from the products' regulatory clearances in more than 35 countries worldwide.

Varian will not acquire any of the Boston Scientific operations. While Varian implements a plan to manufacture and distribute these products, it will work with Boston Scientific under transition services agreements to ensure uninterrupted delivery to customers.

Varian is financing the purchase price of $90 million using cash and proceeds from borrowings. The transaction, which is expected to close around August 2019, is subject to the satisfaction or waiver of customary closing conditions, including approval of the U.S. Federal Trade Commission and the closing of the proposed acquisition of BTG PLC by Boston Scientific Corp.

The combined assets generated revenue of $21.2 million in calendar 2018. Varian expects this transaction to have an immaterial impact on fiscal year 2019 financial results, and the assets to be accretive to GAAP and Non-GAAP earnings per share in fiscal 2020.

For more information: www.varian.com

Related Content

At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting
Expert medical organizations caution that evidence-based ordering of medically necessary imaging exams should not be denied due to widely disagreed upon radiation dose levels tracked in some electronic health record systems (EHRs).
News | Radiation Dose Management | August 17, 2021
August 17, 2021 — Expert medical organizations caution that evidence-based ordering of medically necessary imaging ex
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Mobile C-Arms | July 07, 2021 | By Bhvita Jani
With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resource
An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

News | Coronavirus (COVID-19) | June 23, 2021
June 23, 2021 — The Radiological Society of North America (...
Asheville Radiology Associates announced the unveiling of a new brand including a name, logo and website. The adopted name of Asheville Radiology Associates is now ARA Health Specialists (ARAHS). The updated name more closely reflects ARAHS’ role in leading healthcare in Western North Carolina.
News | Radiology Business | May 03, 2021
May 3, 2021 — Asheville Radiology Associates announced the unveiling of a new brand including a name, logo and websit